Pregnancy, breastfeeding, and other related matters concerning Aimovig

Pregnancy, breastfeeding, and other matters concerning Aimovig

Aimovig, a brand-name injection, is used to prevent migraine headaches. The drug contains the active ingredient erenumab-aooe. However, it's important to note that more comprehensive information about Aimovig can be found in the Medical News Today article.

When it comes to breastfeeding, the safety of Aimovig has not been established. It is unclear if Aimovig passes into breast milk, and as such, breastfeeding mothers may need to stop breastfeeding during their treatment with Aimovig. If considering treatment with Aimovig while breastfeeding, it's crucial to discuss the benefits and risks with a doctor.

Pregnant individuals should also exercise caution when using Aimovig. The current recommendation, based on pregnancy and breastfeeding registry data, is to avoid the use of Aimovig during pregnancy and lactation due to insufficient safety data. Animal studies on Aimovig did not show any risk to the pregnancy, but it's important to remember that animal studies may not accurately predict the safety of drugs for humans.

It's always advisable to consult a doctor or healthcare professional before taking any medication, especially during pregnancy and while breastfeeding. If you are pregnant or breastfeeding and are considering treatment with Aimovig, it's essential to have a thorough discussion with your doctor about the potential risks and benefits.

Moreover, participating in the Aimovig pregnancy registry can provide valuable information on how the drug may affect pregnancy. You can contact 833-244-4083, visit the provided site, or consult a doctor for more information about the registry.

Remember, the drug information provided is subject to change and may not cover all possible uses, precautions, warnings, or adverse effects. Always consult a doctor about the benefits and risks of using Aimovig during pregnancy or breastfeeding.